Insomnia is a widespread sleep disorder, with an estimated prevalence of 10–30% of adults experiencing chronic insomnia and 25–35% reporting transient or occasional insomnia. In patients with moderate ...

The diagnostic challenge is that many patients with OSA do not present with the classic symptoms clinicians often associate ...

Researchers analyzed more than 910,000 adults and found that SARS-CoV-2 infection was associated with a higher adjusted risk ...

Research reveals a hidden genetic link that dictates exactly how your nighttime routine impacts your brain.

Sleep disorders are common among individuals with end-stage renal disease (ESRD) on dialysis and can persist after renal transplantation. This study aims to compare the association of sleep disorders ...

Good-quality sleep is defined by its ability to minimize disturbances, provide adequate duration, and maintain a balanced progression through sleep stages. Sleep disturbance is a common complaint in ...

Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.

Sleep apnea patients may eventually achieve higher quality sleep, thanks to a team of researchers at the University at Buffalo, who have successfully created a prototype encrypted network that uses ...

Tirzepatide reduced sleep apnea events and improved weight loss, reshaping treatment for nighttime breathing disorders.

Sleep affects nearly every chronic condition healthcare wants to manage. here's why cannabinoids like CBN are emerging as ...

TORONTO — Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.